ADAMO, Annalisa
 Distribuzione geografica
Continente #
NA - Nord America 2.756
EU - Europa 2.570
AS - Asia 1.618
SA - Sud America 202
Continente sconosciuto - Info sul continente non disponibili 106
AF - Africa 60
OC - Oceania 13
Totale 7.325
Nazione #
US - Stati Uniti d'America 2.636
RU - Federazione Russa 989
SG - Singapore 542
IT - Italia 479
CN - Cina 449
GB - Regno Unito 272
DE - Germania 268
VN - Vietnam 167
HK - Hong Kong 159
FI - Finlandia 148
BR - Brasile 140
IE - Irlanda 94
SE - Svezia 86
FR - Francia 73
KR - Corea 73
CA - Canada 61
NL - Olanda 43
BD - Bangladesh 42
IN - India 39
ID - Indonesia 36
AR - Argentina 31
ES - Italia 27
AT - Austria 22
JP - Giappone 19
MX - Messico 18
IQ - Iraq 16
PL - Polonia 16
TR - Turchia 15
JM - Giamaica 14
UA - Ucraina 14
AU - Australia 13
ZA - Sudafrica 12
BJ - Benin 11
TW - Taiwan 11
TG - Togo 10
BE - Belgio 9
CL - Cile 9
NG - Nigeria 9
IR - Iran 8
LT - Lituania 6
MA - Marocco 6
SA - Arabia Saudita 6
SV - El Salvador 6
CR - Costa Rica 5
CZ - Repubblica Ceca 5
EC - Ecuador 5
JO - Giordania 5
NI - Nicaragua 5
PK - Pakistan 5
VE - Venezuela 5
CH - Svizzera 4
CW - ???statistics.table.value.countryCode.CW??? 4
CO - Colombia 3
EG - Egitto 3
IL - Israele 3
MY - Malesia 3
PE - Perù 3
PH - Filippine 3
PT - Portogallo 3
UY - Uruguay 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
DZ - Algeria 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
PY - Paraguay 2
RO - Romania 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
BO - Bolivia 1
BW - Botswana 1
CY - Cipro 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
GP - Guadalupe 1
GR - Grecia 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
MO - Macao, regione amministrativa speciale della Cina 1
MR - Mauritania 1
PR - Porto Rico 1
SC - Seychelles 1
SI - Slovenia 1
YT - Mayotte 1
Totale 7.225
Città #
Ashburn 579
Moscow 361
Singapore 290
San Jose 277
Dallas 251
Southend 185
Chandler 170
Verona 163
Munich 161
Hong Kong 138
Beijing 108
Dublin 94
New York 92
Helsinki 91
Council Bluffs 84
Los Angeles 62
The Dalles 58
Ho Chi Minh City 46
Houston 41
Santa Clara 39
Milan 37
Orem 32
Ann Arbor 28
Woodbridge 27
Jinan 26
Seoul 23
Hanoi 22
Jakarta 22
London 21
Shenyang 21
Tianjin 21
Turku 21
Denver 20
Lawrence 20
Princeton 20
Nanjing 19
Buffalo 18
Dong Ket 18
Tokyo 18
Amsterdam 17
Redondo Beach 17
Atlanta 16
Jacksonville 16
Montreal 16
Vienna 16
Warsaw 16
Brooklyn 15
Lappeenranta 15
Seattle 15
São Paulo 15
Chennai 14
Wilmington 14
Frankfurt am Main 13
Redmond 13
Chicago 12
Phoenix 12
Cotonou 11
Dearborn 11
Icheon-si 11
Madrid 11
Stockholm 11
Washington 11
Bologna 10
Lomé 10
Mexico City 10
Poplar 10
Rome 10
Toronto 10
Changsha 9
Columbus 9
Guangzhou 9
McKinney 9
Nuremberg 9
Sindelfingen 9
Zhengzhou 9
Abuja 8
Barnet 8
Cagliari 8
Hangzhou 8
Johannesburg 8
Modena 8
San Francisco 8
Sydney 8
Falkenstein 7
Istanbul 7
Lancaster 7
Manchester 7
Nanchang 7
Ningbo 7
Ankara 6
Baghdad 6
Boston 6
Brussels 6
Da Nang 6
Haikou 6
Jiaxing 6
Jyväskylä 6
Kingston 6
Miami 6
Redwood City 6
Totale 4.337
Nome #
Unraveling the role of lymph node metastasis in PDAC and dCCA progression 401
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients 333
Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53 298
Molecular characterization of msc-derived extracellular vesicles and correlation with their immunomodulatory potential 280
Role of GSK-3 signalling in non-promyelocitic acute myeloid leukemia (AML) cell response to chemotherapy 271
Notch singalling inhibition as a multi-target therapy to overcome bone marrow microenvironment-mediated drug resistance in AML 268
Extracellular vesicles mediate mesenchymal stromal cell-dependent regulation of B cell functions 258
Role of Wnt/β-Catenin Signalling in Acute Myeloid Leukemia (AML) Cell Response to Chemotherapy 256
Rational of targeting WNT/beta-catenin signaling in acute myeloid leukemia (AML) 249
B-cell receptor signaling activity identifies patients with mantle cell lymphoma at higher risk of progression 246
Inhibition of GSK-3 Signalling Enhances Sensitivity of Non-Promyelocitic Acute Myeloid Leukemia (AML) Cell to Chemotherapy 242
CHARACTERIZATION OF MESENCHYMAL STROMAL CELL-DERIVED EXTRACELLULAR VESICLES AND CORRELATION WITH THEIR IMMUNOSUPPRESSIVE PROPERTIES TOWARDS B CELLS 242
Differential and transferable modulatory effects of mesenchymal stromal cell-derived extracellular vesicles on T, B and NK cell functions 227
Extracellular Vesicles Mediate Mesenchymal Stromal Cell-Dependent Regulation of B Cell PI3K-AKT Signaling Pathway and Actin Cytoskeleton 221
Fatal cytokine release syndrome by an aberrant FLIP/STAT3 axis 213
Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC 210
Inhibition of Notch signaling enhances chemosensitivity in B cell precursor acute lymphoblastic leukemia 202
Small Molecule Inhibitors of Microenvironmental Wnt/β-Catenin Signaling Enhance the Chemosensitivity of Acute Myeloid Leukemia 187
Neutralization of NET-associated human ARG1 enhances cancer immunotherapy 186
High-throughput analysis and functional interpretation of extracellular vesicle content in hematological malignancies 179
Local ablation disrupts immune evasion in pancreatic cancer 175
Discovery of highly potent benzimidazole derivatives as indoleamine 2,3-dioxygenase-1 (IDO1) inhibitors: from structure-based virtual screening to in vivo pharmacodynamic activity 173
Circulating IgG4+ Plasmablast Count as a Diagnostic Tool in Autoimmune Pancreatitis 171
Functional dosing of mesenchymal stromal cell-derived extracellular vesicles for the prevention of acute graft-versus-host-disease 161
HS-5 and HS-27A Stromal Cell Lines to Study Bone Marrow Mesenchymal Stromal Cell-Mediated Support to Cancer Development 149
Prognostic impact of Interleukin-8 levels in lung cancer: A meta-analysis and a bioinformatic validation 146
Arginase 1-Based Immune Modulatory Vaccines Induce Anticancer Immunity and Synergize with Anti-PD-1 Checkpoint Blockade. 140
Plasmacytoid Dendritic Cell, Slan+-Monocyte and Natural Killer Cell Counts Function as Blood Cell-Based Biomarkers for Predicting Responses to Immune Checkpoint Inhibitor Monotherapy in Non-Small Cell Lung Cancer Patients 140
Role of mesenchymal stromal cell-derived extracellular vesicles in tumour microenvironment 140
Identification of a Compound Inhibiting Both the Enzymatic and Nonenzymatic Functions of Indoleamine 2,3-Dioxygenase 1 132
Moonlighting Proteins Are Important Players in Cancer Immunology 126
Beneficial Effect of Phenytoin and Carbamazepine on GFAP Gene Expression and Mutant GFAP Folding in a Cellular Model of Alexander's Disease 115
Targeting tumour-reprogrammed myeloid cells: the new battleground in cancer immunotherapy 113
GateMeClass: Gate Mining and Classification of cytometry data 111
Common PHOX2B poly-alanine contractions impair RET gene transcription, predisposing to Hirschsprung disease. 108
B-CELL RECEPTOR SIGNALING ACTIVITY IDENTIFIES PATIENTS WITH MANTLE CELL LYMPHOMA AT HIGHER RISK OF PROGRESSION 101
Structural and functional differences in PHOX2B frameshift mutations underlie isolated or syndromic congenital central hypoventilation syndrome. 80
Pluripotent stem-cell-based screening uncovers sildenafil as a mitochondrial disease therapy 43
c-FLIP as a master regulator of immune homeostasis and disease mechanisms 32
Totale 7.325
Categoria #
all - tutte 24.010
article - articoli 17.960
book - libri 0
conference - conferenze 4.476
curatela - curatele 0
other - altro 1.574
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.020


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022107 0 0 0 5 15 1 5 15 11 3 7 45
2022/2023512 23 62 38 82 34 135 0 38 71 2 19 8
2023/2024538 10 20 32 66 81 92 26 53 8 61 75 14
2024/20251.244 46 45 88 191 46 71 108 104 165 69 119 192
2025/20263.390 199 131 252 570 948 191 298 166 250 246 75 64
2026/2027694 49 71 163 411 0 0 0 0 0 0 0 0
Totale 7.325